Back to search

Article

Effect of Early Treatment Intensity on Progression Independent of Relapse Activity and Disability Accumulation in Multiple Sclerosis

2025-07-18

Abstract excerpt

<h4>Background and Objectives</h4> Treatment initiation strategies for disease modifying therapy in multiple sclerosis (MS) are debated, with recent trends favoring induction over escalation approaches. Whether this impacts risk of progressive disease and long-term accumulation of disability is unclear. <h4>Methods</h4> An observational study of a real-world cohort of patients diagnosed with MS registered in the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fc270167-cec0-5254-9334-88d0567c51a3
DOI
10.1101/2025.07.18.25331653
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of Early Treatment Intensity on Progression Independent of Relapse Activity and Disability Accumulation in Multiple SclerosisDOI 10.1101/2025.07.18.25331653
Quantifying MS Progression in the Era of Highly Effective Therapy: Trial Design ImplicationsSemantic proximity
The role of age in choosing high-efficacy treatment for multiple sclerosis – an Austrian MS Database studySemantic proximity
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.Semantic proximity
The association between disability progression, relapses, and treatment in early relapse onset MS: an observational, multi-center, longitudinal cohort studySemantic proximity
Comparative effectiveness of natalizumab and fingolimod and injectable therapies in patients with pediatric multiple sclerosis: A registry-based retrospective cohort studySemantic proximity
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activitySemantic proximity
A Window to New Insights on Progression Independent of Relapse Activity in Multiple Sclerosis: Role of Therapies and Current PerspectiveSemantic proximity
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsSemantic proximity
Biomarkers of Progression Independent of Relapse Activity—Can We Actually Measure It Yet?Semantic proximity
Effect of Cumulative Exposure to Ocrelizumab on Memory B‐Cell Repopulation Dynamics in Multiple SclerosisSemantic proximity
The 2013 clinical course descriptors for multiple sclerosis: A clarification.Semantic proximity
Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes.Semantic proximity
Select a neighboring publication to make it the new centre.